# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-014324
Filing Date
2025-06-09
Accepted
2025-06-09 16:30:21
Documents
3
Period of Report
2025-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm | DEF 14A | 1068318
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 346110
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 164988
| Complete submission text file | 0001641172-25-014324.txt |  | 1740737

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15911 | Film No.: 251034507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)